Propanc Biopharma, Inc. (PPCB)

CIK 1517681 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Propanc Biopharma, Inc..

Recent SEC filings

FiledFormAccession number
Aug 21, 2026DEF 14C0001493152-26-039522
Aug 5, 2026PRE 14C0001493152-26-036041
Jul 27, 2026EFFECT9999999995-26-002465
Jul 17, 2026S-10001493152-26-033807
Jul 14, 20268-K0001493152-26-033173
May 14, 202610-Q0001493152-26-023210
Apr 20, 2026EFFECT9999999995-26-001258
Apr 10, 2026S-10001493152-26-016228
Mar 31, 2026DEF 14C0001493152-26-013734
Mar 20, 2026PRE 14C0001493152-26-011711
Mar 19, 2026PRE 14A0001493152-26-011697
Mar 6, 2026424B30001493152-26-009199
Feb 26, 20268-K0001493152-26-008196
Feb 24, 2026EFFECT9999999995-26-000658
Feb 19, 2026S-1/A0001493152-26-007492
Feb 17, 202610-Q0001493152-26-007052
Feb 2, 2026S-10001493152-26-004792
Jan 30, 2026424B30001493152-26-004312
Jan 9, 2026EFFECT9999999995-26-000139
Jan 7, 20268-K0001493152-26-000834
Dec 30, 2025S-10001493152-25-029472
Dec 29, 2025DEF 14C0001493152-25-029430
Dec 10, 2025PRE 14C0001493152-25-027099
Nov 14, 2025SCHEDULE 13G/A0001753926-25-001800
Nov 14, 202510-Q0001493152-25-023213